Skip to main content

Advertisement

SpringerLink
Log in

Influence of common clinical variables on intraoperative parathyroid hormone monitoring during surgery for primary hyperparathyroidism

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background

Intraoperative monitoring of parathyroid hormone (IOPTH) is a reliable method of predicting the cure of primary hyperparathyroidism (PHPT). The aim of this study is to assess whether common clinical variables (CCV) frequently encountered in patients with PHPT may affect the magnitude of PTH drop or the likelihood of patients meeting the intraoperative cure criterion.

Design

Patients who were surgically cured from PHPT caused by single gland disease (SGD) and had full IOPTH protocol (4 measurements) were stratified according to age, gland weight, renal function, vitamin D status and severity of hypercalcemia. The percentage of IOPTH drop and the frequency of patients who had true positive IOPTH test results were compared among groups.

Results

762 patients had surgery for PHPT, of whom 746 were (98%) cured. Of these 746 patients, 511 who had SGD and a full IOPTH protocol were included in this study. The median IOPTH drop was significantly higher among younger patients, those with severe hypercalcaemia at 5, 10, 15 min after gland excision, giant glands (at 5-min only), patients with vitamin D deficiency (at 10, 15 min), and those with normal renal function (at 15 min only). The likelihood of the patients meeting the intraoperative cure criterion was not significantly affected among the groups except in patients with mild hypercalcaemia, who were significantly less likely to have 50% IOPTH drop than those with severe hypercalcaemia at all time points. The frequency of mildly hypercalcaemic patients who met cure criterion was significantly improved by extending measurement to 15 min.

Conclusions

IOPTH monitoring has the ability to mitigate the variability of IOPTH kinetics associated with most clinical variables. Mildly hypercalcemic patients in particular may benefit from waiting for 15-min measurement before any surgical decision is made.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gopinath P, Mihai R (2011) Hyperparathyroidism. Surgery (Oxford) 29(9):451–458

    Article  Google Scholar 

  2. Bilezikian JP, Cusano NE, Khan AA, Liu J-M, Marcocci C, Bandeira F (2016) Primary hyperparathyroidism. Nat Rev Dis Primers 2:16033

    Article  PubMed  Google Scholar 

  3. Madkhali T, Alhefdhi A, Chen H, Elfenbein D (2016) Primary hyperparathyroidism. Ulus Cerrahi Derg 32(1):58–66

    PubMed  PubMed Central  Google Scholar 

  4. Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99(10):3561–3569

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sackett WR, Barraclough B, Reeve TS, Delbridge LW (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 37(9):1055–1059

    Article  Google Scholar 

  6. Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394(5):761–764

    Article  PubMed  Google Scholar 

  7. Wilhelm SM, Wang TS, Ruan DT et al (2016) The american association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151(10):959–968

    Article  PubMed  Google Scholar 

  8. Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W (2009) Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg 394(5):843–849

    Article  PubMed  Google Scholar 

  9. Chen H, Pruhs Z, Starling JR, Mack E (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138(4):583–587

    Article  PubMed  Google Scholar 

  10. Udelsman R, Donovan PI (2004) Open minimally invasive parathyroid surgery. World J Surg 28(12):1224–1226

    Article  PubMed  Google Scholar 

  11. Smith N, Magnuson JS, Vidrine DM, Kulbersh B, Peters GE (2009) Minimally invasive parathyroidectomy: use of intraoperative parathyroid hormone assays after 2 preoperative localization studies. Arch Otolaryngol Head Neck Surg 135(11):1108–1111

    Article  PubMed  Google Scholar 

  12. Shawky M, Abdel Aziz T, Morley S et al (2019) Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 90(2):277–284

    Article  CAS  Google Scholar 

  13. Grant CS, Thompson G, Farley D, van Heerden J (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140(5):472–478

    Article  PubMed  Google Scholar 

  14. Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134(6):973–979

    Article  PubMed  Google Scholar 

  15. Pallan S, Rahman MO, Khan AA (2012) Diagnosis and management of primary hyperparathyroidism. BMJ 344:e1013

    Article  PubMed  Google Scholar 

  16. Gannage-Yared MH, Abboud B, Amm-Azar M et al (2009) Predictors of intra-operative parathyroid hormone decline in subjects operated for primary hyperparathyroidism by minimally invasive parathyroidectomy. J Endocrinol Invest 32(2):160–164

    Article  CAS  PubMed  Google Scholar 

  17. Bishop B, Wang B, Parikh PP, Lew JI (2015) Intraoperative parathormone monitoring mitigates age-related variability in targeted parathyroidectomy for patients with primary hyperparathyroidism. Ann Surg Oncol 22(Suppl 3):S655–S661

    Article  PubMed  Google Scholar 

  18. Oldham SB, Finck EJ, Singer FR (1978) Parathyroid hormone clearance in man. Metabolism 27(8):993–1001

    Article  CAS  PubMed  Google Scholar 

  19. Sunkara B, Cohen MS, Miller BS, Gauger PG, Hughes DT (2018) Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism. Surgery 163(1):42–47

    Article  PubMed  Google Scholar 

  20. Sohn JA, Oltmann SC, Schneider DF, Sippel RS, Chen H, Elfenbein DM (2015) Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate? Am J Surg 209(3):483–487

    Article  PubMed  Google Scholar 

  21. Clark MJ, Pellitteri PK (2009) Assessing the impact of low baseline parathyroid hormone levels on surgical treatment of primary hyperparathyroidism. Laryngoscope 119(6):1100–1105

    Article  CAS  PubMed  Google Scholar 

  22. Agarwal G, Sadacharan D, Ramakant P, Shukla M, Mishra SK (2012) The impact of vitamin D status and tumor size on the intraoperative parathyroid hormone dynamics in patients with symptomatic primary hyperparathyroidism. Surg Today 42(12):1183–1188

    Article  CAS  PubMed  Google Scholar 

  23. Adler JT, Sippel RS, Chen H (2010) 25-hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidism. Ann Surg Oncol 17(11):2958–2962

    Article  PubMed  Google Scholar 

  24. Souberbielle JC, Boutten A, Carlier MC et al (2006) Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 70(2):345–350

    Article  CAS  PubMed  Google Scholar 

  25. Riss P, Kaczirek K, Heinz G, Bieglmayer C, Niederle B (2007) A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery 142(3):398–404

    Article  PubMed  Google Scholar 

  26. Harrison BJ, Triponez F (2009) Intraoperative adjuncts in surgery for primary hyperparathyroidism. Langenbecks Arch Surg 394(5):799–809

    Article  PubMed  Google Scholar 

  27. Shawky M, Abdel-Aziz T, Kurzawinski T (2018) Modern parathyroid surgery and intra-operative hormone monitoring; present status, future concepts. J Steroids Horm Sci 9(190):2

    Google Scholar 

  28. Rolighed L, Heickendorff L, Hessov I, Garne JP, Rodt SA, Christiansen P (2004) Primary hyperparathyroidism: intraoperative PTH-measurements. Scand J Surg 93(1):43–47

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

M.S.S. would like to thank the Ministry of Higher Education, Missions sector, Egypt and the British Council for their support through Newton‐Musharafa programme via the Egyptian Cultural Bureau in London.

Author information

Authors and Affiliations

  1. Centre for Endocrine Surgery, University College London Hospital and London Clinic, 250 Euston Road, London, NW1 2PG, UK

    M. S. Shawky, T. E. Abdel-Aziz, M. C. De Jong, V. Rozalén García & T. R. Kurzawinski

  2. Department of General Surgery, Alexandria University, Alexandria, Egypt

    M. S. Shawky, M. F. Sakr, A. S. Nabawi & T. E. Abdel-Aziz

  3. Department of Clinical Biochemistry, University College London Hospital, London, UK

    F. Lam, C. Soromani & J. W. Honour

  4. Department of Anaesthesia, University College London Hospital, London, UK

    J. Smart

Authors
  1. M. S. Shawky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. F. Sakr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. S. Nabawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. E. Abdel-Aziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. C. De Jong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Rozalén García
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Soromani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Smart
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. W. Honour
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. T. R. Kurzawinski
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MS Shawky: study conception and design; acquisition, analysis and interpretation of data; drafting of manuscript. MF Sakr: interpretation of data, critical revision. AS Nabawi: interpretation of data, critical revision. TE Abdel-Aziz: study conception and design; critical revision. MC de Jong: acquisition of data; analysis of data. V Rozalén García: acquisition of data; analysis and interpretation of data. F Lam: acquisition of data; analysis and interpretation of data. C Soromani: acquisition of data; analysis and interpretation of data. J Smart: acquisition of data, critical revision. JW Honour: ioPTH service initiation, review of data and manuscript. TR Kurzawinski: analysis and interpretation of data; drafting of manuscript.

Corresponding author

Correspondence to M. S. Shawky.

Ethics declarations

Conflict of interest

The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.

Research involving human participants and/or animals

The study was approved by the institutional research committee. This article does not contain any studies on animals performed by any of the authors.

Informed consent

Patients were not consented for this study due to its retrospective nature.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shawky, M.S., Sakr, M.F., Nabawi, A.S. et al. Influence of common clinical variables on intraoperative parathyroid hormone monitoring during surgery for primary hyperparathyroidism. J Endocrinol Invest 43, 1205–1212 (2020). https://doi.org/10.1007/s40618-020-01201-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-020-01201-z

Keywords

Search

Navigation